/Investor DB

Premier Partners — 2021 Investments

3 investments dated 2021 · listed companies and verified rows first · show all

Iksuda Therapeuticsiksuda.comin𝕏Jun 2021 · $47M

Iksuda develops antibody-drug conjugates (ADCs) with enhanced tumor specificity for treating difficult-to-treat cancers.

BiotechDeep TechMedical Devices

Superb AIsuperb-ai.comin𝕏Series B · Jan 2021 · $16M

Superb AI provides an industrial AI stack for vision and analytics applications across mobility, security, defense, logistics, and manufacturing.

AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Hyun Kim(Founder)inMoonsu Cha(ML Engineer)inJonghyuk Lee(Machine Learning Engineer)inJungkwon Lee(Founder)inHyundong Lee(Founder)inHyunsoo Kim(Founder)

Co-investorsAtinum Investment Co. Ltd.Duke Capital PartnersGrant Park VenturesKT investment Inc.KT Strategic Investment Fund 4Point Reyes Management+7 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Sorrento Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.